{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T04:24:28Z","timestamp":1789273468722,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,9,14]],"date-time":"2011-09-14T00:00:00Z","timestamp":1315958400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2011,9,14]],"date-time":"2011-09-14T00:00:00Z","timestamp":1315958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Acetazolamide is commonly given to chronic obstructive pulmonary disease (COPD) patients with metabolic alkalosis. Little is known of the pharmacodynamics of acetazolamide in the critically ill. We undertook the pharmacodynamic modeling of bicarbonate response to acetazolamide in COPD patients under mechanical ventilation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This observational, retrospective study included 68 invasively ventilated COPD patients who received one or multiple doses of 250 or 500 mg of acetazolamide during the weaning period. Among the 68 investigated patients, 207 time-serum bicarbonate observations were available for analysis. Population pharmacodynamics was modeled using a nonlinear mixedeffect model. The main covariates of interest were baseline demographic data, Simplified Acute Physiology Score II (SAPS II) at ICU admission, cause of respiratory failure, co-prescription of drugs interfering with the acid-base equilibrium, and serum concentrations of protein, creatinin, potassium and chloride. The effect of acetazolamide on serum bicarbonate levels at different doses and in different clinical conditions was subsequently simulated<jats:italic>in silico<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The main covariates interacting with acetazolamide pharmacodynamics were SAPS II at ICU admission (<jats:italic>P<\/jats:italic>= 0.01), serum chloride (<jats:italic>P<\/jats:italic>&lt; 0.001) and concomitant administration of corticosteroids (<jats:italic>P<\/jats:italic>= 0.02). Co-administration of furosemide significantly decreased bicarbonate elimination. Acetazolamide induced a decrease in serum bicarbonate with a dose-response relationship. The amount of acetazolamide inducing 50% of the putative maximum effect was 117 \u00b1 21 mg. According to our model, an acetazolamide dosage &gt; 500 mg twice daily is required to reduce serum bicarbonate concentrations &gt; 5 mmol\/L in the presence of high serum chloride levels or coadministration of systemic corticosteroids or furosemide.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study identified several covariates that influenced acetazolamide pharmacodynamics and could allow a better individualization of acetazolamide dosing when treating COPD patients with metabolic alkalosis.<\/jats:p><\/jats:sec>","DOI":"10.1186\/cc10448","type":"journal-article","created":{"date-parts":[[2011,9,15]],"date-time":"2011-09-15T04:57:30Z","timestamp":1316062650000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Population pharmacodynamic model of bicarbonate response to acetazolamide in mechanically ventilated chronic obstructive pulmonary disease patients"],"prefix":"10.1186","volume":"15","author":[{"given":"Nicholas","family":"Heming","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Faisy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u00efk","family":"Urien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,14]]},"reference":[{"key":"9749_CR1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1183\/09031936.06.00025805","volume":"27","author":"AD Lopez","year":"2006","unstructured":"Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, Schmid V, Buist S: Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006, 27: 397-412. 10.1183\/09031936.06.00025805","journal-title":"Eur Respir J"},{"key":"9749_CR2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1183\/09031936.05.00024804","volume":"26","author":"H Gunen","year":"2005","unstructured":"Gunen H, Hacievliyagil SS, Kosar F, Mutlu LC, Gulbas G, Pehlivan E, Sahin I, Kizkin O: Factors affecting survival of hospitalised patients with COPD. Eur Respir J 2005, 26: 234-241. 10.1183\/09031936.05.00024804","journal-title":"Eur Respir J"},{"key":"9749_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1136\/bmj.326.7382.185","volume":"326","author":"JV Lightowler","year":"2003","unstructured":"Lightowler JV, Wedzicha JA, Elliott MW, Ram FS: Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. BMJ 2003, 326: 185. 10.1136\/bmj.326.7382.185","journal-title":"BMJ"},{"key":"9749_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000083402","volume":"72","author":"G Gursel","year":"2005","unstructured":"Gursel G: Determinants of the length of mechanical ventilation in patients with COPD in the intensive care unit. Respiration 2005, 72: 61-67. 10.1159\/000083402","journal-title":"Respiration"},{"key":"9749_CR5","first-page":"354","volume":"46","author":"A Khanna","year":"2001","unstructured":"Khanna A, Kurtzman NA: Metabolic alkalosis. Respir Care 2001, 46: 354-365.","journal-title":"Respir Care"},{"key":"9749_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/BF00256061","volume":"11","author":"P Berthelsen","year":"1985","unstructured":"Berthelsen P, G\u00f8thgen I, Husum B, Jacobsen E: Oxygen uptake and carbon dioxide elimination after acetazolamide in the critically ill. Intensive Care Med 1985, 11: 26-29.","journal-title":"Intensive Care Med"},{"key":"9749_CR7","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/00003246-198903000-00006","volume":"17","author":"S Brimioulle","year":"1989","unstructured":"Brimioulle S, Berre J, Dufaye P, Vincent JL, Degaute JP, Kahn RJ: Hydrochloric acid infusion for treatment of metabolic alkalosis associated with respiratory acidosis. Crit Care Med 1989, 17: 232-236. 10.1097\/00003246-198903000-00006","journal-title":"Crit Care Med"},{"key":"9749_CR8","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1183\/09031936.98.12061242","volume":"12","author":"ER Swenson","year":"1998","unstructured":"Swenson ER: Carbonic anhydrase inhibitors and ventilation: a complex interplay of stimulation and suppression. Eur Respir J 1998, 12: 1242-1247. 10.1183\/09031936.98.12061242","journal-title":"Eur Respir J"},{"key":"9749_CR9","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1097\/00003246-199907000-00004","volume":"27","author":"JE Mazur","year":"1999","unstructured":"Mazur JE, Devlin JW, Peters MJ, Jankowski MA, Iannuzzi MC, Zarowitz BJ: Single versus multiple doses of acetazolamide for metabolic alkalosis in critically ill medical patients: a randomized, double-blind trial. Crit Care Med 1999, 27: 1257-1261. 10.1097\/00003246-199907000-00004","journal-title":"Crit Care Med"},{"key":"9749_CR10","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00134-010-1795-7","volume":"36","author":"C Faisy","year":"2010","unstructured":"Faisy C, Mokline A, Sanchez O, Tadi\u00e9 JM, Fagon JY: Effectiveness of acetazolamide for reversal of metabolic alkalosis in weaning COPD patients from mechanical ventilation. Intensive Care Med 2010, 36: 859-863. 10.1007\/s00134-010-1795-7","journal-title":"Intensive Care Med"},{"key":"9749_CR11","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","volume":"176","author":"KF Rabe","year":"2007","unstructured":"Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J, Global Initiative for Chronic Obstructive Pulmonary Disease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176: 532-555. 10.1164\/rccm.200703-456SO","journal-title":"Am J Respir Crit Care Med"},{"key":"9749_CR12","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1183\/09031936.00010206","volume":"29","author":"JM Boles","year":"2007","unstructured":"Boles JM, Bion J, Connors A, Herridge M, Marsh B, Melot C, Pearl R, Silverman H, Stanchina M, Vieillard-Baron A, Welte T: Weaning from mechanical ventilation. Eur Respir J 2007, 29: 1033-1056. 10.1183\/09031936.00010206","journal-title":"Eur Respir J"},{"key":"9749_CR13","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","volume":"270","author":"JR Le Gall","year":"1993","unstructured":"Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European\/North American multicenter study. JAMA 1993, 270: 2957-2963. 10.1001\/jama.270.24.2957","journal-title":"JAMA"},{"key":"9749_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s002280050422","volume":"54","author":"I Yano","year":"1998","unstructured":"Yano I, Takayama A, Takano M, Inatani M, Tanihara H, Ogura Y, Honda Y, Inui K: Pharmacokinetics and pharmacodynamics of acetazolamide in patients with transient intraocular pressure elevation. Eur J Clin Pharmacol 1998, 54: 63-68. 10.1007\/s002280050422","journal-title":"Eur J Clin Pharmacol"},{"key":"9749_CR15","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/j.1552-4604.1998.tb05791.x","volume":"38","author":"WA Ritschel","year":"1998","unstructured":"Ritschel WA, Paulos C, Arancibia A, Agrawal MA, Wetzelsberger KM, L\u00fccker PW: Pharmacokinetics of acetazolamide in healthy volunteers after short- and long-term exposure to high altitude. J Clin Pharmacol 1998, 38: 533-539.","journal-title":"J Clin Pharmacol"},{"key":"9749_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2307\/1390807","volume":"5","author":"R Ihaka","year":"1996","unstructured":"Ihaka R, Gentleman R: R: a language for data analysis and graphics. J Comput Graphic Stat 1996, 5: 299-314. 10.2307\/1390807","journal-title":"J Comput Graphic Stat"},{"key":"9749_CR17","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/bja\/58.5.512","volume":"58","author":"P Berthelsen","year":"1986","unstructured":"Berthelsen P, G\u00f8thgen I, Husum B, Jacobsen E: Dissociation of renal and respiratory effects of acetazolamide in the critically ill. Br J Anaesth 1986, 58: 512-516. 10.1093\/bja\/58.5.512","journal-title":"Br J Anaesth"},{"key":"9749_CR18","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1164\/ajrccm.160.5.9903088","volume":"160","author":"L Teppema","year":"1999","unstructured":"Teppema L, Dahan A: Acetazolamide and breathing: Does a clinical dose alter peripheral and central CO 2 sensitivity? Am J Resp Crit Care Med 1999, 160: 1592-1597.","journal-title":"Am J Resp Crit Care Med"},{"key":"9749_CR19","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1164\/ajrccm.163.2.9911075","volume":"163","author":"HF Kiwull-Sch\u00f6ne","year":"2001","unstructured":"Kiwull-Sch\u00f6ne HF, Teppema LJ, Kiwull PJ: Low-dose acetazolamide does affect respiratory muscle function in spontaneously breathing anesthetized rabbits. Am J Respir Crit Care Med 2001, 163: 478-483.","journal-title":"Am J Respir Crit Care Med"},{"key":"9749_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1113\/jphysiol.1996.sp021587","volume":"495","author":"M Wagenaar","year":"1996","unstructured":"Wagenaar M, Teppema L, Berkenbosch A, Olievier C, Folgering H: The effect of low-dose acetazolamide on the ventilatory CO 2 response curve in the anaesthetized cat. J Physiol 1996, 495: 227-237.","journal-title":"J Physiol"},{"key":"9749_CR21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/10408369991239286","volume":"36","author":"NR Webster","year":"1999","unstructured":"Webster NR, Kulkarni V: Metabolic alkalosis in the critically ill. Crit Rev Clin Lab Sci 1999, 36: 497-510. 10.1080\/10408369991239286","journal-title":"Crit Rev Clin Lab Sci"},{"key":"9749_CR22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0022-3565(24)38896-2","volume":"295","author":"Y Uway","year":"2000","unstructured":"Uway Y, Saito H, Hashimoto Y, Inui KI: Interaction and transport of thiazide diuretics, loop diuretics, and acetazolamide via rat renal organic anion transporter rOAT1. J Pharmacol Exp Ther 2000, 295: 261-265.","journal-title":"J Pharmacol Exp Ther"},{"key":"9749_CR23","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1139\/y74-138","volume":"52","author":"TH Maren","year":"1974","unstructured":"Maren TH: Chemistry of the renal reabsorption of bicarbonate. Can J Physiol Pharmacol 1974, 52: 1041-1050. 10.1139\/y74-138","journal-title":"Can J Physiol Pharmacol"},{"key":"9749_CR24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1152\/physrev.1967.47.4.595","volume":"47","author":"TH Maren","year":"1967","unstructured":"Maren TH: Carbonic anhydrase: chemistry, physiology, and inhibition. Physiol Rev 1967, 47: 595-781.","journal-title":"Physiol Rev"},{"key":"9749_CR25","first-page":"136","volume":"10","author":"PA Preisig","year":"1987","unstructured":"Preisig PA, Toto RD, Alpern RJ: Carbonic anhydrase inhibitors. Ren Physiol 1987, 10: 136-159.","journal-title":"Ren Physiol"},{"key":"9749_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1164\/arrd.1983.127.4.405","volume":"127","author":"JB Skatrud","year":"1983","unstructured":"Skatrud JB, Dempsey JA: Relative effectiveness of acetazolamide versus medroxyprogesterone acetate in correction of chronic carbon dioxide retention. Am Rev Respir Dis 1983, 127: 405-412.","journal-title":"Am Rev Respir Dis"},{"key":"9749_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1378\/chest.124.2.459","volume":"124","author":"KH Groenewegen","year":"2003","unstructured":"Groenewegen KH, Scholas AM, Wouters EF: Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003, 124: 459-467. 10.1378\/chest.124.2.459","journal-title":"Chest"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc10448.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/cc10448\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc10448.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:25:54Z","timestamp":1741652754000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/cc10448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,14]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2011,10]]}},"alternative-id":["9749"],"URL":"https:\/\/doi.org\/10.1186\/cc10448","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,14]]},"assertion":[{"value":"15 May 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R213"}}